{"id":"NCT00635817","sponsor":"Abbott","briefTitle":"A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty","officialTitle":"A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg Formulations in Children With Central Precocious Puberty","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2010-01","completion":"2010-06","firstPosted":"2008-03-14","resultsPosted":"2011-02-09","lastUpdate":"2011-11-02"},"enrollment":84,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Puberty, Precocious"],"interventions":[{"type":"DRUG","name":"Leuprolide acetate 11.25 mg","otherNames":["ABT-818","leuprolide acetate","Lupron"]},{"type":"DRUG","name":"Leuprolide acetate 30 mg","otherNames":["ABT-818","leuprolide acetate","Lupron"]}],"arms":[{"label":"Leuprolide acetate 11.25 mg","type":"EXPERIMENTAL"},{"label":"Leuprolide acetate 30 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine if 11.25 and 30 mg formulations of leuprolide are effective in treating children with Central Precocious Puberty (CPP).","primaryOutcome":{"measure":"Percentage of Participants With Suppression of Peak Stimulated Luteinizing Hormone (<4 mIU/mL) From Month 2 Through Month 6","timeFrame":"Month 2 through 6","effectByArm":[{"arm":"Leuprolide Acetate 11.25 mg - Treatment Naive","deltaMin":76.2,"sd":9.29},{"arm":"Leuprolide Acetate 11.25 mg - Previous Treatment","deltaMin":80.7,"sd":8.69},{"arm":"Leuprolide Acetate 30 mg - Treatment Naive","deltaMin":90.5,"sd":6.41},{"arm":"Leuprolide Acetate 30 mg - Previous Treatment","deltaMin":100,"sd":0}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":17},"locations":{"siteCount":25,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["22344198"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":21},"commonTop":["Injection Site Pain","Headache","Pyrexia","Cough","Upper Respiratory Tract Infection"]}}